ESR is 120 mm\hr What's further treatment
Reading File
Finding Sources
Searching PubMed
abdominal tuberculosis mesenteric lymphadenopathy diagnosis treatment
Finding Sources
Searching PubMed
abdominal tuberculosis diagnosis treatment
Reading File
Finding Sources
Finding Sources
Reading Article
Based on the USG findings and the markedly elevated ESR (120 mm/hr), here is a structured management plan:
Clinical Summary
The USG shows:
- Multiple enlarged necrotic mesenteric lymph nodes (largest 12×9 mm)
- Minimal ascites
- Radiologist impression: Favor/Suspect (F/S/O) Koch's (Tuberculous) etiology
Combined with ESR 120 mm/hr, this picture is highly suggestive of abdominal/peritoneal tuberculosis.
Immediate Next Steps (as advised by radiologist)
1. CECT Abdomen & Pelvis
- Better characterizes lymph nodes (rim-enhancing necrotic nodes = classic for TB)
- Evaluates peritoneal thickening, bowel involvement, hepatic/splenic lesions
- Rules out lymphoma or carcinomatosis
2. Mantoux Test (Tuberculin Skin Test)
- A strongly positive result (≥10 mm induration in immunocompetent, ≥5 mm in immunocompromised) supports TB diagnosis
Additional Investigations to Order in Parallel
| Investigation | Purpose |
|---|---|
| IGRA (QuantiFERON-Gold) | More specific than Mantoux; less cross-reactivity |
| Ascitic fluid analysis | Tap the minimal ascites: cell count, protein, LDH, ADA (adenosine deaminase), SAAG, Xpert MTB/RIF |
| Ascitic fluid ADA | ADA >40 U/L has high sensitivity/specificity for tuberculous peritonitis |
| Chest X-ray / HRCT chest | To rule out concurrent pulmonary TB (often co-exists) |
| Sputum AFB smear & culture (if respiratory symptoms) | Rule out pulmonary source |
| HIV serology | Mandatory — TB/HIV co-infection affects regimen |
| LFT, CBC, RFT | Baseline before starting ATT |
| Blood culture (BACTEC) | Rule out disseminated/miliary TB if febrile |
| Xpert MTB/RIF on ascitic fluid | Rapid molecular diagnosis (though sensitivity is moderate ~50–60% in peritoneal TB) |
| ESR, CRP, LDH | Baseline inflammatory markers for monitoring response |
If ascitic fluid is insufficient, consider laparoscopic biopsy of peritoneal deposits or lymph node biopsy (FNAC/core needle) for histology (caseating granuloma) and culture.
Treatment: Anti-Tubercular Therapy (ATT)
Once diagnosis is confirmed (or if a diagnostic trial is warranted in a TB-endemic region when all workup is inconclusive):
Standard 6-Month Regimen (RNTCP/WHO for drug-susceptible TB)
| Phase | Duration | Drugs |
|---|---|---|
| Intensive Phase | 2 months (2HRZE) | Isoniazid (H) + Rifampicin (R) + Pyrazinamide (Z) + Ethambutol (E) daily |
| Continuation Phase | 4 months (4HR) | Isoniazid + Rifampicin daily |
For abdominal TB, 6 months of ATT is sufficient in most cases (same as pulmonary TB). — Jha et al., Indian J Gastroenterol, 2023 [PMID: 36899289]
Response Assessment at 2 Months
- Resolution of ascites
- Reduction in lymph node size on repeat USG
- Symptomatic improvement (fever, weight gain, ESR trending down)
- If no response → reconsider diagnosis, check drug susceptibility (MDR-TB)
Key Drug Doses (Adult)
| Drug | Daily Dose |
|---|---|
| Isoniazid | 5 mg/kg (max 300 mg) + Pyridoxine 25–50 mg (prevents peripheral neuropathy) |
| Rifampicin | 10 mg/kg (max 600 mg) |
| Pyrazinamide | 25 mg/kg (max 2 g) |
| Ethambutol | 15–20 mg/kg (max 1.6 g) |
Monitoring During ATT
- LFTs at 2, 4, 8 weeks — hepatotoxicity is the major concern (INH, RIF, PZA are all hepatotoxic)
- Stop ATT if transaminases >5× ULN or bilirubin >3 mg/dL
- Visual acuity and color vision checks with ethambutol (optic neuritis risk)
- Uric acid monitoring (pyrazinamide → hyperuricemia)
Corticosteroids
Not routinely indicated for isolated mesenteric TB. Consider prednisolone 1–2 mg/kg/day only if:
- Severe peritonitis with dense adhesions
- Threatening intestinal obstruction
- Impending lymph node rupture
Red Flags Requiring Surgical Referral
- Acute abdomen (perforation/obstruction)
- Failure to respond to ATT at 2 months
- Recurrent intestinal obstruction (may need stricturoplasty or resection)
Bottom line: The clinical-radiological picture strongly favors abdominal Koch's disease. Proceed with CECT abdomen, Mantoux, ascitic fluid ADA + Xpert, baseline bloods (LFT/CBC/HIV), then initiate 2HRZE / 4HR pending or upon confirmation. Monitor ESR, clinical symptoms, and repeat USG at 2 months as objective response criteria.
Sources: Tintinalli's Emergency Medicine; Jha DK et al. Evidence-based approach to diagnosis and management of abdominal tuberculosis. Indian J Gastroenterol 2023 [PMID: 36899289]
This is a shared conversation. Sign in to Orris to start your own chat.